[1] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
[2] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
[3] |
Gao Fan, Wang Ping, Du Chao, Chu Yanliu.
Research progress on intestinal flora and non-surgical treatment of the colorectal cancer
[J]. Journal of International Oncology, 2024, 51(6): 376-381.
|
[4] |
Qian Xiaotao, Shi Ziyi, Hu Ge.
A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(3): 151-156.
|
[5] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
[6] |
Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.
Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(2): 89-94.
|
[7] |
Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.
Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients
[J]. Journal of International Oncology, 2024, 51(1): 37-42.
|
[8] |
Cui Tenglu, Lyu lu, Sun Pengfei.
Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 548-552.
|
[9] |
An Rong, Liu Meihua, Wang Peichen, Wang Xiaohui.
Research progress of Nrf2 in ovarian cancer
[J]. Journal of International Oncology, 2023, 50(8): 493-497.
|
[10] |
Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.
Research progress on the application of combining radiotherapy and systemic therapy in breast cancer
[J]. Journal of International Oncology, 2023, 50(6): 362-367.
|
[11] |
Lyu Lu, Sun Pengfei.
Gut flora and cervical cancer
[J]. Journal of International Oncology, 2023, 50(6): 373-376.
|
[12] |
Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.
Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version)
[J]. Journal of International Oncology, 2023, 50(4): 193-201.
|
[13] |
Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.
Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance
[J]. Journal of International Oncology, 2023, 50(4): 227-230.
|
[14] |
Shi Xaioqi, Wang Hongyan.
Research progress on the interaction between gut microbiota and radiation enteritis
[J]. Journal of International Oncology, 2023, 50(4): 244-247.
|
[15] |
Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.
Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases
[J]. Journal of International Oncology, 2023, 50(3): 138-143.
|